Yoshifumi Saisho, MD, PhD
- Director, Saisho Diabetes Clinic, Tokyo, Japan
- Adjunct Professor, Keio University School of Medicine, Tokyo, Japan
- Adjunct Clinical Professor, Kyorin University School of Medicine, Tokyo, Japan
- Academic Councilor, Japan Diabetes Society
- Board member, International Society of Personalized Medicine
- Board member, Certification Board for Diabetes Educators in Japan
- Editorial board, Diabetes Research and Clinical Practice
- Editorial board, Diabetes, Obesity and Metabolism
- Editorial board, BMC endocrine disorders
Biography
Dr. Saisho received his medical degree in 1998 and his PhD degree in 2009, both from the Keio University School of Medicine in Tokyo. Before obtaining his current position as assistant professor, Dr. Saisho completed a three-year postdoctoral fellowship at the Larry L. Hillblom Islet Research Center at the University of California-Los Angeles’s David Geffen School of Medicine (Prof. Peter C. Butler). Dr. Saisho’s area of interest is Diabetology, especially beta cell dysfunction in diabetes. Dr. Saisho is the author or coauthor of more than 100 publications.
How does your research relate to the SDGs?
Prevention is a key to “well-being”. Type 2 diabetes is a progressive disease, with decline in beta cell function. Since impairment of beta cell function started more than 10 years before the development of hyperglycemia, earlier intervention for type 2 diabetes is critical to preserve beta cell function. Having that beta cell expansion in response to obesity in humans is limited, insulin resistance inevitably leads to an increment in beta cell workload, even before the onset of diabetes. Longstanding overwork of beta cell results in beta cell malfunction, and eventually beta cell death, like “Karoshi” in Japanese. Once the number of beta cells starts to decrease, the rest of beta cells must work harder to maintain normoglycemia, forming the vicious cycle. Therefore, the lifestyle modification including healthy eating and physical activity should direct towards the reduction in beta cell workload, and protection of beta cell will be the path to the prevention of diabetes, as well as achievement of the SDGs.
- Beyond glucose: A beta-cell centric approach to prevent type 2 diabetes (https://www.youtube.com/watch?v=tPE66_w7uR4)
Why did you decide to go into your field of research?
In Japan, there are many patients with type 2 diabetes without obesity. Moreover, despite lifestyle modification, diabetes cannot be cured in most patients. Based on these facts, I hypothesized that beta cell dysfunction is the key to explore the pathogenesis of type 2 diabetes.
How has knowledge of topic developed over the course of your career?
I conducted my research at UCLA (Prof. Peter C Butler) between 2006 and 2009 as a postdoctoral fellow. This experience gave me the opportunity to develop my career thereafter.
What are your hopes for progress in the future?
Based on the beta cell centric concept of diabetes which we proposed, medical staffs and patients with type 2 diabetes should work together to protect beta cell. The beta cell centric concept will empower the people with type 2 diabetes, diminish the stigma, and enhance the advocacy among the people with type 2 diabetes.
Follow the Topic
-
BMC Endocrine Disorders
This is an open access, peer-reviewed journal that considers articles on the characterization, prevention, diagnosis and treatment of endocrine disorders.
Related Collections
With Collections, you can get published faster and increase your visibility.
Diabetes in older adults
BMC Endocrine Disorders is calling for submissions to our Collection, Diabetes in older adults.
The prevalence of diabetes among the elderly population is rapidly increasing, creating a pressing public health concern that warrants extensive research and understanding. As individuals age, physiological changes, including alterations in insulin sensitivity and the presence of comorbidities, complicate diabetes management. Furthermore, the heterogeneous nature of diabetes in older adults often leads to underdiagnosis or misdiagnosis, emphasizing the need for focused research on this demographic. This Collection invites contributions that delve into the various aspects of diabetes in older age, encompassing its pathophysiology, management strategies, and the unique challenges faced by elderly patients.
Understanding diabetes in the elderly is crucial for developing effective treatment protocols and improving quality of life for this vulnerable group. Recent advancements in geriatric care and diabetes management have highlighted the importance of personalized medicine, integrating technology and patient-centered approaches. Research has shown that tailored interventions can significantly enhance glycemic control while minimizing adverse effects, leading to better health outcomes. As the aging population continues to grow, it is imperative that we expand our knowledge base and refine care strategies to meet the needs of elderly individuals with diabetes.
Continued research in this area may lead to groundbreaking advances in the management of diabetes in older adults, including the development of innovative therapies and technologies that cater specifically to their needs. Enhanced understanding of the interplay between aging, diabetes, and comorbidities may also foster more effective strategies for prevention and early intervention. Ultimately, ongoing efforts can pave the way for improved health outcomes and enhanced quality of life for the elderly living with diabetes.
Topics that are welcome include, but are not limited to, the following:
Management strategies for diabetes in older adults
Insulin resistance and aging
Geriatric care approaches for diabetes
Diabetes-related morbidity in the elderly
Evidence-based nutritional therapy
Exercise therapy
This Collection supports and amplifies research related to SDG 3: Good Health & Well-being
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jul 06, 2026
Continuous glucose monitoring in diabetes
BMC Endocrine Disorders is calling for submissions to our Collection, Continuous glucose monitoring in diabetes.
Continuous glucose monitoring (CGM) has revolutionized diabetes management by offering a comprehensive picture of glycemic status, and providing real-time glucose data to support prompt and informed decisions. This Collection aims to explore the latest advancements in CGM technology, including the integration of wearable sensors, non-invasive methods, and enhanced sensor accuracy. As diabetes prevalence continues to rise globally, the need for effective, convenient, and easy-to-wear monitoring solutions that can improve glycemic control and overall health outcomes has never been more urgent.
The significance of CGM technology lies in its potential to transform diabetes care by allowing for proactive management rather than reactive measures. Recent innovations have led to more accurate sensors and user-friendly devices, empowering individuals with diabetes to achieve better blood glucose control. Additionally, CGM systems can facilitate personalized insulin therapy and enhance patient-provider communication. As we gather research for this Collection, it is vital to consider how these advances can be optimized to further improve quality of life for those living with diabetes.
With ongoing research and development, the future of CGM is promising. We may see the emergence of more sophisticated wearable technologies that not only track glucose levels but also integrate with artificial intelligence to predict fluctuations, recommend lifestyle changes, and optimize insulin delivery. Such innovations could lead to more personalized and effective diabetes management strategies, ultimately improving patient outcomes and reducing the burden of diabetes-related complications.
Topics that are welcome include, but are not limited to, the following:
Advances in wearable glucose monitoring technology
Integration of non-invasive sensors in diabetes management
Enhancing sensor accuracy for better glycemic control
Real-time glucose tracking and its impact on insulin therapy
We invite researchers to submit their work to this Collection that will showcase cutting-edge research in CGM, exploring various dimensions such as wearable technology, glycemic control, and innovative solutions for diabetes management.
This Collection supports and amplifies research related to SDG 3: Good Health & Well-being
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Apr 10, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in